Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy

Hyperammonemia has been reported to be associated with patients who receive valproic acid (VPA) therapy. This study aimed to determine the risk factors for hyperammonemia in patients with epilepsy treated with VPA. One hundred and fifty-eight adult patients with epilepsy aged older than 17 years who...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Tseng, Yu-Lung, Huang, Chi-Ren, Lin, Chih-Hsiang, Lu, Yan-Ting, Lu, Cheng-Hsien, Chen, Nai-Ching, Chang, Chiung-Chih, Chang, Wen-Neng, Chuang, Yao-Chung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616274/
https://ncbi.nlm.nih.gov/pubmed/25192484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000066
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak